Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01193712

Endocardial Pacing in On-table Non-responders in Cardiac Resynchronization Therapy

Non-Responders in Cardiac Resynchronization Therapy

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Catharina Ziekenhuis Eindhoven · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether left ventricular endocardial pacing exhibits a greater acute hemodynamic response during biventricular pacing in patients who do not show this response to standard cardiac resynchronization therapy.

Detailed description

Cardiac resynchronisation therapy (CRT) with biventricular pacemakers and implantable cardiac defibrillators (ICD) has proven to be a valuable therapy in selected patients with systolic heart failure, ameliorating both morbidity and mortality. However, with current selection criteria and implant technique, about 20 to 30 % of patients remain non-responders. Non-responders might be due to failing selection criteria or methodology in casu echocardiography. However, an important number of non-responders may result of sub-optimal positioning of the left ventricular lead, remote from the site of delayed activation. Endocardial left ventricular stimulation may ameliorate the shortcomings of epicardial stimulation. The advantage of an endocardial approach is the absence of phrenic nerve stimulation which regularly complicates epicardial pacing, a more predictable pacing threshold and much less restriction to position the lead in the area of interest. Transseptal left ventricular endocardial pacing has already been used in patients in whom standard epicardial pacing was not applicable.

Conditions

Interventions

TypeNameDescription
PROCEDUREtemporary left ventricular endocardial pacinga temporary pacemaker lead will be introduced through the aortic valve to evaluate the effect of left ventricular endocardial pacing. Four different pacing sites (basal and apical septal, basal and apical lateral) will be investigated with measurement of LV dP/dtmax. Afterwards, the endocardial pacing lead will be removed.

Timeline

Start date
2010-08-01
Primary completion
2012-04-01
Completion
2012-04-01
First posted
2010-09-02
Last updated
2015-02-03

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT01193712. Inclusion in this directory is not an endorsement.